Pemetrexed, cisplatin

DRUG2 trials

Sponsors

University Hospital, Brest, Yonsei University

Conditions

Lung CancerSarcoma

Phase 2

Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)

CompletedNCT00744900

University Hospital, BrestLung Cancer

Start: 2008-09-30Updated: 2009-07-28

A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma

CompletedNCT03809637

Yonsei UniversitySarcoma

Start: 2017-01-10End: 2021-06-30Updated: 2024-12-18

Related Papers

A phase II, multi-cohort study with pemetrexed plus cisplatin combination in patients with relapsed or refractory advanced soft tissue sarcoma: Leiomyosarcoma cohort (ALBATROSS-SARC-LMS01).

Journal of Clinical Oncology2026-05-27

Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial.

2021-09-023 citations